---
tags:
  - Drug
  - Antibiotic
title: Bacterial protein synthesis inhibitors
date created: Friday, September 29th 2023, 11:20:24 am
date modified: Wednesday, October 4th 2023, 12:31:40 pm
---
## Aminoglycosides
_Gentamicin, Tobramycin, Amikacin_
- For Gram -ve infections ($\downarrow$ activity against most Gram +ve and anaerobes)
- Poor GI absorption
- **Tobramycin** has $\uparrow$ activity against Pseudomonas
- Amikacin has least resistance
- Nephrotoxic and ototoxic

## Macrolides
_Azithromycin, clarithromycin, erythromycin_
- Gram +ve cocci, syphilis, chlamydia
- Not enterococci or staphylococci
- Cytochrome P450 inhibitor (less with azithromycin)
	- $\uparrow$ warfarin
	- rhabdomyolysis with statins
	- $\uparrow$ calcineurin inhibitor levels

## Tetracyclines and derivatives
_Tetracycline, doxycycline_
- Exacerbation of COPD, chlamydia, Lyme disease, mycoplasma, rickettsia, brucella, Anthrax, Syphilis, MRSA, malaria prophylaxis  
- Contraindicated in pregnancy and children <8 y/o

_Tigecycline_
- Gram +ve & -ve including $\beta$-lactam-resistant strains
- Dose adjust in liver dysfunction
## Other

| Antibiotic      | Indications                                                      | Considerations                           |
| --------------- | ---------------------------------------------------------------- | ---------------------------------------- |
| Clindamycin     | Gram +ve cocci (not enterococci), MRSA, anaerobes                | $\uparrow$ risk C. diff                  |
| Linezolid       | Gram +ve cocci, MRSA, VRE, anaerobes, mycobacteria               | MAOI check interactions                  |
| Chloramphenicol | Gram +ve & -ve, anaerobes, mycoplasma, chlamydia, conjunctivitis | Systemic use limited by myelosuppression |
| Fusidic acid    | Staphylococci                                                    | $\uparrow$ LFTs                                         |
